Cardiol Therapeutics Inc. (CRDL) vs Fortress Biotech, Inc. (FBIOP)

A side-by-side comparison of Cardiol Therapeutics Inc. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cardiol Therapeutics Inc. logo
CRDL
Cardiol Therapeutics Inc.
$154M
$1.34HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Fortress Biotech, Inc. logo
FBIOP
Fortress Biotech, Inc.
$140M
$17.75HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT

Total return — CRDL vs FBIOP

growth of $100 · dividends reinvested · last 8y
CRDL -64.7% (-12.2%/yr)FBIOP +114.3% (+10.0%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120232025$35$214
CRDL FBIOP

CRDL vs FBIOP: by the numbers

  • •CRDL is the larger company ($154M vs $140M market cap).
  • •FBIOP is profitable (163.32% net margin) while CRDL runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCRDLFBIOP
P/E ratioN/A6.62
Forward P/EN/A6.96
P/S ratioN/A2.04
P/B ratio9.130.85
FCF yieldN/A90.06%

Profitability

MetricCRDLFBIOP
Gross margin0.00%62.53%
Operating margin0.00%-111.00%
Net margin0.00%163.32%
ROE-155.34%68.12%
ROIC-165.56%-10.85%

Growth (annualized)

MetricCRDLFBIOP
Revenue CAGR (5Y)N/A5.39%
Total return CAGR (5Y)-18.36%0.05%

Frequently asked

Is CRDL or FBIOP more profitable?
FBIOP runs the higher net margin — CRDL at 0.00% versus FBIOP at 163.32%.
How have CRDL and FBIOP total returns compared?
Over the past 5 years, CRDL delivered -18.36% and FBIOP delivered 0.05% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRDL analysisFull FBIOP analysisInteractive comparison tool

Dig into the metrics

Fortress Biotech P/E ratioCardiol Therapeutics ROEFortress Biotech ROECardiol Therapeutics operating marginFortress Biotech operating marginCardiol Therapeutics revenue growthFortress Biotech revenue growthCardiol Therapeutics free cash flowFortress Biotech free cash flow

Cardiol Therapeutics & Fortress Biotech appear in these rankings

Highest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.